Global increases in cases
https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19—20-april-2021
Cases, increased for past 8 weeks
Cases, + 5.2 million (7 days)
Deaths increased for past 5 weeks
Deaths, + 83,000 (7 days) up 7% on last week
South-East Asia, India, Western Pacific Region
United Arab Emirates
Population 9.8 million
Sinopharm and Pfizer
At least one dose, 65%
Two doses, 38%
Considering restricting movements of unvaccinated
National Emergency Crisis and Disasters Management
Delaying or refraining from taking the vaccine will pose a threat to the safety of society … as it poses a major challenge to the national efforts to recover
strict measures are being considered
restrict the movement of unvaccinated individuals
implement preventive measures such as restricting entry to some places and having access to some services
Israel
Some indoor venues, theatres and restaurants
Italy
National government decree, that if a health care worker, hospitals, nursing homes, or other facilities where they are in contact with patients
Then they have to accept a different work position with no contact with patients, or they will be dismissed.
Introducing Green Pass while waiting for the official EU health passport
Indian airline flight, Delhi to Hong Kong, 4th April
https://nypost.com/2021/04/20/dozens-of-passengers-test-positive-for-covid-on-flight-from-india/
Up to 188 passengers
All tested negative within 72 hours of boarding
53 tested positive
Emerged during mandatory three-week quarantine
Also several cases from Mumbai flights
Introduced an emergency 2 week ban on flights from India, Pakistan and the Philippines
Brazil
Johnson & Johnson coronavirus vaccine, EMA, 20th April
Confirms positive risk benefit analysis
https://www.jnj.com/johnson-johnson-covid-19-vaccine-roll-out-to-resume-in-europe-following-european-medicines-agency-ema-reviewema-confirms-overall-benefit-risk-profile-remains-positive
https://www.washingtonpost.com/nation/2021/04/21/coronavirus-covid-live-updates-us/
https://edition.cnn.com/2021/04/20/europe/ema-johnson-johnson-vaccine-blood-clot-ruling-intl/index.html
https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-janssen
Concluded that a warning about unusual blood clots with low blood platelets should be added to the product information
Should be listed as very rare side effect of the vaccine
Based on 7 million vaccinations in the US, 8 cases
All cases occurred in people under 60
Within three weeks after vaccination
The majority in women
Specific risk factors have not been confirmed
Plausible explanation, an immune response, similar to heparin induced thrombocytopenia, HIT
Report for senior review
Shortness of breath
Chest pain
Leg swelling
Persistent abdominal (belly) pain
Neurological symptoms, such as severe and persistent headaches or blurred vision
Tiny blood spots under the skin beyond the site of the injection
Source